北尾 洋之

Medicine & Life Sciences

1. Fanconi Anemia 100%
2. Trifluridine 83%
3. DNA 57%
4. trifluridine tipiracil 50%
5. DNA Repair 48%
6. Mutation 43%
7. Breast Neoplasms 42%
8. DNA Damage 41%
9. Chickens 41%
10. Neoplasms 40%
11. Esophageal Squamous Cell Carcinoma 38%
12. Colorectal Neoplasms 36%
13. Recombinational DNA Repair 35%
14. Fluorouracil 34%
15. Cell Line 33%
16. DNA Replication 30%
17. Methylation 29%
18. Immunoglobulin Genes 28%
19. Aneuploidy 27%
20. Fanconi Anemia Complementation Group Proteins 26%
21. Loss of Heterozygosity 26%
22. Stomach Neoplasms 25%
23. Proteins 24%
24. Phosphorylation 24%
25. Triple Negative Breast Neoplasms 24%
26. Genes 23%
27. Gene Conversion 22%
28. Chromosomal Instability 22%
29. Homologous Recombination 20%
30. DNA Breaks 19%
31. Oxaliplatin 19%
32. Genomic Instability 18%
33. Survival 18%
34. Carcinogenesis 18%
35. thymidine kinase 1 17%
36. Double-Stranded DNA Breaks 17%
37. B7-H1 Antigen 16%
38. Vimentin 16%
39. S Phase 16%
40. DNA Helicases 16%
41. Genetic Recombination 15%
42. 1,2-cyclohexanediamine 14%
43. Staining and Labeling 14%
44. Adenocarcinoma of Lung 13%
45. Gefitinib 13%
46. Esophageal Neoplasms 13%
47. Pharmaceutical Preparations 12%
48. p53 Genes 12%
49. 8-Hydroxy-2'-Deoxyguanosine 12%
50. Chromatin 11%